8 agosto 2014
Probiotics have shown promise for treating patients with recurrent Clostridium difficile infections. However, their safety and quality control requires further study – especially in immunocompromised patients, concludes a review paper. Probiotics – beneficial microorganisms deliberately introduced into the body – have been used in some patients as an adjunct treatment with some success. However, a detailed investigation on the use of probiotics for infected patients is still needed to determine their real efficacy.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/LTCtiLGOYBA/140807215529.htm
